Our Bureau Marquee investors Malabar Investments picked up a part of the promoter’s stake in Neogen Chemicals from the open market on June 3. In a disclosure to the stock exchanges, Neogen Chemicals, manufacturers of bromine-based and lithium-based specialty chemicals, said promoters divested 11.26 lakh shares on June 3 through open market at around ₹473.30 a share. A significant portion of this sale (10.47 lakh shares) was bought by Malabar India Fund and Malabar Value Fund.
On Thursday, the stock closed at ₹469.6, up 2.06 per cent, on the BSE.
The promoters remain firmly committed to the business and its future. Following the transactions, the aggregate stake of promoters/promoter group fell to 64.32 per cent from 70.01 per cent of the company’s equity share capital, Neogen Chemicals said in the statement.
“With this transaction, another high-quality institutional shareholder has been added in the company’s ownership, re-affirming the confidence already displayed by several existing marquee investors in its long-term growth prospects,” the statement added.
Neogen came out with a ₹132-crore IPO in April 2019 at an issue price of ₹215. Since then the company’s stock hit a 52-week high of ₹554.8 and low ₹290.6 on the BSE.
The company reported a 28 per cent rise in revenues to ₹306.12 crore and 37 per cent jump in profit after tax to ₹28.66 crore for FY20.
Malabar Investments is a leading India-focussed investment firm founded in 2008 with the backing of reputed institutional value investors from the US and Asia.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.